News | July 07, 2025
SPARC incorporates subsidiary ‘Genokine Biotech’
The wholly owned subsidiary will carry on the business of all types of research and development and other related services
The wholly owned subsidiary will carry on the business of all types of research and development and other related services
The CEP certification for Metformin Hydrochloride aligns with the company's strategy to penetrate stringently regulated markets
This recertification of Company's OECD GLP is testimony to company's unwavering commitment to maintain international quality standards at the facility
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
USFDA inspection at Alembic Pharma's Bioequivalence facility
The Alathur facility specializes in the production of Cephalosporin antibiotics
Dyrupeg will be available as 6 mg solution for injection in prefilled syringe and is intended for the reduction in the duration of neutropenia
Teriflunomide is a novel disease-modifying agent that was approved for use in the treatment of multiple sclerosis
_256_384.jpg)
Mesalazine is used to treat inflammatory bowel disease
The company will receive GMP compliance certificate which will further help to accelerate the business growth across the globe
Subscribe To Our Newsletter & Stay Updated
